thiazolidines has been researched along with Cardiomegaly in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Grisanti, LA; Tanner, MA; Thomas, TP | 1 |
| Deguchi, H; Enzan, N; Ide, T; Ikeda, M; Ikeda, S; Ishikita, A; Matsushima, S; Okabe, K; Sada, M; Shinohara, K; Tadokoro, T; Tsutsui, H; Yamamoto, T | 1 |
| Amoroso, S; Bompadre, S; Castaldo, P; Gratteri, S; Lariccia, V; Magi, S; Nasti, AA | 1 |
3 other study(ies) available for thiazolidines and Cardiomegaly
| Article | Year |
|---|---|
Death receptor 5 contributes to cardiomyocyte hypertrophy through epidermal growth factor receptor transactivation.
Topics: Animals; Animals, Newborn; Cardiomegaly; Cell Enlargement; Cell Survival; Cells, Cultured; ErbB Receptors; GATA4 Transcription Factor; Gene Expression Regulation; Hypertrophy; Male; MAP Kinase Signaling System; Matrix Metalloproteinases; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Phthalimides; Rats, Sprague-Dawley; Receptors, TNF-Related Apoptosis-Inducing Ligand; Thiazolidines | 2019 |
DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)-Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1-Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathw
Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Heart Rate; Histone Deacetylases; Mice; Myocytes, Cardiac; NADPH Oxidase 4; Oxidative Stress; Pyrazoles; Rats; Signal Transduction; Thiazolidines | 2020 |
Gram-negative endotoxin lipopolysaccharide induces cardiac hypertrophy: detrimental role of Na(+)-Ca(2+) exchanger.
Topics: Animals; Benzyl Compounds; Cardiomegaly; Cell Line; Lipopolysaccharides; Male; Myoblasts, Cardiac; Rats; Rats, Wistar; Sodium-Calcium Exchanger; Thiazolidines; Up-Regulation | 2015 |